Cervical carcinosarcoma: Case report and review of the literature
DOI:
https://doi.org/10.18597/rcog.3096Keywords:
Carcinosarcoma, uterus, therapy, prognosisAbstract
Objective: To report the case of a patient with cervical carcinosarcoma and intra-abdominal bleeding, and to review the available literature on the treatment and prognosis of this condition.
Materials and methods: Case report of an 84-year-old patient who presented with an abdominal mass and urinary tract obstruction. During hospital stay, she developed intra-abdominal bleeding with signs of shock, requiring total abdominal hysterectomy with bilateral salpyngo-oophorectomy, hypogastric artery ligation and pelvic packing as interventions to control bleeding. Histology reported a diagnosis of carcinosarcoma of the uterine cervix. The patient evolved adequately and was referred for oncologic management. The search in the literature was conducted in the Medline vía PubMed, SciELO and Ovid databases, using the terms “uterine carcinosarcoma” “treatment” “cancer treatment” “treatment review” and “treatment outcome”. The search was limited by language type but not by year of publication.
Results: Of the references, 19 met the inclusion and exclusion criteria, and they were predominantly case reports. The clinical stage most frequently reported was FIGO IB in close to 53% of cases, and the most frequent presentation was genital bleeding associated with a pelvic mass. With an average follow-up of 15 months, survival in patients receiving radiotherapy or taken to surgery is 17% and 68%, respectively. Of the patients taken to surgery as primary treatment, 63% remained disease-free during the first two years of follow-up, with a frequency of nearly 100% during the same period when radiotherapy was given after surgery.
Conclusions: Cervical carcinosarcoma is an infrequent condition whose most common clinical manifestation is the presence of genital bleeding accompanied by a pelvic mass. Surgery, radiotherapy and chemotherapy are therapeutic options available for the treatment of this entity. However, regardless of the treatment provided, survival prognosis in women with this disease is lower than in women with squamous cell carcinoma or adenocarcinoma. Further studies of high methodological quality are required to assess the safety and effectiveness of the various interventions used as therapeutic approach to this entity.Author Biographies
Carmen Doris Garzón-Olivares
Médico cirujano; especialista en Obstetricia y Ginecología. Docente, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Hospital Universitario Nacional, Bogotá (Colombia). cdgarzono@unal.edu.co
Daniel Otálvaro Cortés-Díaz
Médico cirujano; especialista en Obstetricia y Ginecología. Docente, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Hospital Universitario Nacional, Bogotá (Colombia).
Edith Angel-Müller
Médico cirujano; especialista en Obstetricia y Ginecología. Docente, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Hospital Universitario Nacional, Bogotá (Colombia).
Giovanni Enrique Riaño-Castellanos
Médico cirujano; especialista en Obstetricia y Ginecología. Docente, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Hospital Universitario Nacional, Bogotá (Colombia).
Nathalia Mora-Soto
Médico cirujano; residente de Obstetricia y Ginecología, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Bogotá (Colombia).
Bernarda Jinneth Acosta-Forero
Médico cirujano; especialista en patología. Docente, Departamento de patología, Universidad Nacional de Colombia, Hospital Universitario Nacional, Bogotá (Colombia).
References
Kurman RJ. International Agency for Research on Cancer, World Health Organization. WHO Classification of tumours of female reproductive organs, 4th ed. International Agency for Research on Cancer; 2014.
Kim M, Lee C, Choi H, Ko J-K, Kang G, Chun K. Carcinosarcoma of the uterine cervix arising from Müllerian ducts. Obstet Gynecol Sci. 2015;58:251-5.
Iida T, Yasuda M, Kajiwara H, Minematsu T, Osamura RY, Itoh J, et al. Case of uterine cervical carcinosarcoma. J Obstet Gynaecol Res. 2005;31:404-8.
Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, et al. Gynecologic Cancer InterGroup (GCIG) Consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S55-60.10.1097/IGC.0000000000000228.
Ferlay J, Soerjomataram EM, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [visitado 2017 abr 17]. Disponible en: http://globocan.iarc.fr
Ministerio de Salud y Protección Social. Guía de Práctica Clínica para la detección y manejo de lesiones precancerosas de cuello uterino. Guía para profesionales. Colombia; 2014 [visitado 2017 Abr 17]. Disponible en: http://www.cancer.gov.co/Gu%C3%ADas-y-Protocolos/Gu %C3 %ADas-de-Practica-clinica/LPC-Guia-profesionales.pdf.
Bansal S, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD. Sarcoma of the cervix: Natural history and outcomes. Gynecol Oncol. 2010;118:134-8.
Arend R, Doneza JA, Wright JD. Uterine carcinosarcoma. Curr Opin Oncol. 2011;23:531-6.
Takeshima Y, Amatya VJ, Nakayori F, Nakano T, Iwaoki Y, Daitoku K, et al. Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papilloma virus infection. Int J Gynecol Pathol. 2002;21:186-90.
Piura B, Meirovitz M, Shaco-Levy R. Carcinosarcoma of the uterine cervix initially interpreted as myoma nascens. J Obstet Gynaecol. 2007;27:539-40.
Wright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, et al. Cervical sarcomas: An analysis of incidence and outcome. Gynecol Oncol. 2005;99:348-51. https://doi.org/10.1016/j.ygyno.2005.06.021
Meguro S, Yasuda M, Shimizu M, Kurosaki A, Fujiwara K. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: A case report and review of the literature. Diagn Pathol. 2013;7:74.
Menczer J. Review of recommended treatment of uterine carcinosarcoma. Curr Treat Options Oncol. 2015;16:53.
KimyonComert G, Turkmen O, Karalok A, Basaran D, Bulbul D, Turan T. Therapy modalities, prognostic factors, and outcome of the primary cervical carcinosarcoma: Meta-analysis of extremely rare tumor of cervix. Int J Gynecol Cancer. 2017;27:1957-69.
Xu C, Nishi H, Isaka K. A case of uterine cervical carcinosarcoma recurrence who obtained a clinically complete response by ifosfamide, doxorubicin and cisplatin. Eur J Gynaecol Oncol. 2011;32:119-21.
Tseng CE, Chen CH, Chen SJ, Chi CL. Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: A case report and review of the literature. Int J Clin Exp Pathol. 2014;7:1212-7.
Siebald E, Puga O, Madrid P. Tumores müllerianos mixtos de cuello uterino. Rev chil obstet ginecol. 2008;73:128-32.
Park HM, Park MH, Kim YJ, Chun SH, Ahn JJ, Kim CI, et al. Mullerian adenosarcoma with sarcomatous overgrowth of the cervix presenting as cervical polyp: A case report and review of the literature. Int J Gynecol Cancer. 2004;14:1024-9.
Mohan H, Garg S, Handa U. Sarcomatoid carcinoma of the cervix: Case report of a rare entity. Arch Gynecol Obstet. 2008;277:571-3.
Miyazawa K, Hernandez E. Cervical carcinosarcoma: A case report. Gynecol Oncol. 1986;23:376-80.
Luo Y, Yao Q, Ren C, Ding X, Hu A, Liu C. HPV infection status in cervical metaplastic carcinomas. J Clin Pathol. 2015;68:170-2.
Laterza R, Seveso A, Zefiro F, Formenti G, Mellana L, Donadello N. et al. Carcinosarcoma of the uterine cervix: Case report and discussion. Gynecol Oncol. 2007;107(1 Suppl 1):S98-100.
Kadota K, Haba R, Ishikawa M, Kushida Y, Katsuki N, Hayashi T, et al. Uterine cervical carcinosarcoma with heterologous mesenchymal component: A case report and review of the literature. Arch Gynecol Obstet. 2009;280:839-43.
Farley JH, Taylor RR. Cervical carcinosarcoma occurring after subtotal hysterectomy, a case report. Gynecol Oncol. 1997;67:322-4.
Connor JP. Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: Case report and laboratory correlates. Gynecol Oncol. 2006;103:349-53.
Abidi A, Menn K, Sherman A, Konia T, Azodi M. Cervical carcinosarcoma: A case report. J Reprod Med. 2008;53:138-40.
Sánchez Díaz L. Carcinosarcoma del cuello uterino. Informe de un Caso. Rev Colomb Obstet Ginecol. 1973;24:283-9.
McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12:687-90.
Gokce ZK, Turan T, Karalok A, Tasci T, Ureyen I, Ozkaya E, et al. Clinical outcomes of uterine carcinosarcoma: Results of 94 patients. Int J Gynecol Cancer. 2015;25:279-87.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Revista Colombiana de Obstetricia y Ginecología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
